R3TA – 20mg

Retatrutide (Triple Agonist Analog) – Research Peptide

Retatrutide is a synthetic peptide analog studied in scientific literature for its interaction with multiple receptor pathways involved in metabolic and endocrine signaling. Classified as a multi-receptor agonist, this compound has been investigated for its activity across glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor systems.

In experimental models, compounds within this class have generated significant interest due to their ability to engage multiple signaling pathways simultaneously. This multi-pathway activity allows researchers to explore complex receptor interactions, signaling cascades, and regulatory mechanisms within controlled laboratory environments. As a result, Retatrutide has become a valuable compound in studies focused on advanced peptide-receptor dynamics and integrated metabolic signaling models.

Retatrutide is supplied as a lyophilized powder, enabling precise handling, storage, and reconstitution for research and analytical applications. Its structural design and receptor interaction profile make it particularly useful for investigating multi-receptor engagement and peptide-based pathway modulation in vitro.

At Kinesin Peptide Research, Retatrutide is provided strictly for research purposes only and is intended for use in controlled laboratory and analytical settings by qualified professionals. Each batch is produced with an emphasis on purity, consistency, and research-grade standards to support reliable and reproducible experimental outcomes.

Research Applications May Include:

• Multi-receptor pathway studies (GLP-1, GIP, glucagon receptors)

• Endocrine and metabolic signaling models

• Peptide-receptor interaction analysis

• Integrated pathway and signaling cascade research

• Experimental studies involving incretin-related mechanisms